Keyword: pharmaceutical industry

cable and satellite TV California Canada cannabis cap-and-trade capital capital allocation capital asset pricing model capital budgeting capital flows capital formation capital income capital markets capital outflows capital regulation capital requirements capital stock capitalism CAPM carbon emissions carbon leakage carbon prices carbon tax carbon taxes careers CARES Act cars cash central bank independence central banks charitable deductions charity charter schools chief executives childrearing children China Christmas climate change climate policies climate policy climate targets closing auction clusters college admissions college athletes college tuition colonialism commercial banks commercial property commodity markets communism competition competition policy competitiveness concentration congestion congestion charges congestion pricing Congress Congressional Budget Office Connecticut consolidation constitutional amendment constitutions consumer price index consumer prices consumer protection consumer welfare consumption consumption insurance contraception conventions coronabonds Coronavirus corporate boards corporate executives corporate investment corporate performance corporate reporting corporate reproting corporate social responsibility corporate tax corporate taxes cost disease cost of capital cost of living cost-benefit analysis costs of living Council of Economic Advisors COVID-19 credibility revolution credit credit cards credit risk creditors crime crypto assets cryptocurrencies cryptocurrency Cuba culture currencies currency currency manipulation currency reserves customers
US

Prescription Drugs

This US survey examines (a) Allowing Medicare to negotiate prices with pharmaceutical companies will lead to a substantial reduction in the costs of prescription drugs for US retirees; (b) Allowing imports of medicines from Canada will lead to a substantial reduction in the costs of prescription drugs for US consumers without compromising safety
US

Medicare Funding

This US survey examines (a) If it is implemented, the proposed increase in the tax rate on earned and business income above $400,000 in the Biden budget, along with other proposed changes to Medicare, would extend the solvency of the Medicare program for the next 25 years; (b) If it is implemented, the proposed reform of Medicare drug negotiations in the Biden budget is likely to lead to a substantial reduction in drug prices for beneficiaries; (c) If it is implemented, the proposed reform of Medicare drug negotiations in the Biden budget is likely to lead to a substantial reduction in the development of beneficial new drugs
US

Mandatory Medicare II

This week’s IGM Economic Experts Panel statements: A) Replacing the current US health insurance system (including employer-based health insurance, ACA exchange policies, and Medicaid) with universal ‘Medicare for All’ (mandatory enrollment in a modified version of the existing traditional Medicare program with drug coverage and no cost-sharing of any form, and current Medicare reimbursement rates) funded by federal taxes would lead to lower aggregate medical debt among patients. B) Replacing the current US health insurance system as outlined in a) would lead to lower aggregate innovation in the pharmaceutical industry. C) Replacing the current US health insurance system as outlined in a) would improve health outcomes for the majority of the population.